S&P Global (SPGI) Reaches $159.88 After 8.00% Up Move; HTG Molecular Diagnostics (HTGM) Had 3 Bullish Analysts

October 12, 2017 - By sdlfksdklf klsdf

Among 3 analysts covering HTG Molecular Diagnostics (NASDAQ:HTGM), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. HTG Molecular Diagnostics had 7 analyst reports since August 24, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, August 22 by Rodman & Renshaw. The rating was maintained by Canaccord Genuity with “Buy” on Tuesday, November 24. The firm has “Buy” rating given on Friday, July 28 by H.C. Wainwright. The stock has “Buy” rating by Canaccord Genuity on Monday, August 24. The rating was maintained by H.C. Wainwright with “Buy” on Wednesday, August 9. H.C. Wainwright maintained the stock with “Buy” rating in Tuesday, September 12 report. The company was maintained on Thursday, June 29 by H.C. Wainwright. See HTG Molecular Diagnostics Inc (NASDAQ:HTGM) latest ratings:

12/09/2017 Broker: H.C. Wainwright Rating: Buy New Target: $6.0 Maintain
09/08/2017 Broker: H.C. Wainwright Rating: Buy New Target: $6.0000 Maintain
28/07/2017 Broker: H.C. Wainwright Rating: Buy New Target: $6.0000 Maintain
29/06/2017 Broker: H.C. Wainwright Rating: Buy New Target: $6.0000 Maintain

The stock of S&P Global Inc (NYSE:SPGI) is a huge mover today! About 188,258 shares traded. S&P Global Inc (NYSE:SPGI) has risen 29.28% since October 12, 2016 and is uptrending. It has outperformed by 12.58% the S&P500.The move comes after 6 months positive chart setup for the $41.28 billion company. It was reported on Oct, 12 by Barchart.com. We have $172.67 PT which if reached, will make NYSE:SPGI worth $3.30B more.

S&P Global Inc., formerly McGraw Hill Financial Inc., is a well-known provider of ratings, benchmarks, analytics and data to the capital and commodity markets around the world. The company has market cap of $41.28 billion. The Firm operates through three divisions: Ratings, which provides credit ratings, research and analytics to investors, issuers and other market participants; Market and Commodities Intelligence, which offers multi-asset-class data, research and analytical capabilities that integrate cross-asset analytics and desktop services, and deliver their clients in the commodity and energy markets access to information, data, analytic services and pricing and benchmarks, and S&P Dow Jones Indices , which is an index well-known provider that maintains a range of valuation and index benchmarks for investment advisors, wealth managers and institutional investors. It has a 18.67 P/E ratio.

Analysts await S&P Global Inc (NYSE:SPGI) to report earnings on November, 2. They expect $1.51 EPS, up 5.59% or $0.08 from last year’s $1.43 per share. SPGI’s profit will be $389.87 million for 26.47 P/E if the $1.51 EPS becomes a reality. After $1.72 actual EPS reported by S&P Global Inc for the previous quarter, Wall Street now forecasts -12.21% negative EPS growth.

HTG Molecular Diagnostics, Inc. is a commercial-stage firm that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The company has market cap of $23.47 million. The Company’s HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. It currently has negative earnings. The Company’s HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.